Research Paper Volume 16, Issue 5 pp 4579—4590
A novel classification predicts prognosis and drug sensitivity in osteosarcoma based on alterations in gene sets
Figure 5. Differences of tumor immune infiltrating cells in osteosarcoma between two groups.